Tonix Pharmaceuticals Holding Corp Earnings

The next earnings date for Tonix Pharmaceuticals Holding Corp is August 10, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Tonix Pharmaceuticals Holding Corp Earnings

Report Date	Estimated Earnings Per Share
08/10/2026	$-2.88

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Tonix Pharmaceuticals Holding Corp Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
05/11/2026	After Market	$-2.93	-18.05%
03/12/2026	After Market	$-3.98	-22.32%
11/10/2025	After Market	$-3.59	1.82%
08/11/2025	After Market	$-3.86	-17.71%
05/12/2025	After Market	$-2.84	13.80%
03/18/2025	After Market	$-9.77	97.53%
11/12/2024	Before Market	$-23	92.31%
08/16/2024	After Market	$-1,928	-477.45%
05/13/2024	After Market	$-576	54.75%
04/01/2024	After Market	$-2,752	48.69%
11/09/2023	After Market	$-5,856	-20.41%
08/10/2023	After Market	$-8,576	4.63%
05/08/2023	Before Market	$-10,400	-5.11%
03/13/2023	Before Market	$-11,200	36.16%
11/07/2022	Before Market	$-13,800	33.68%
08/08/2022	Before Market	$-24,400	17.23%
05/09/2022	Before Market	$-32,000	-5.03%
03/14/2022	Before Market	$-44,800	-14.38%
11/08/2021	Before Market	$-32,000	29.97%
08/09/2021	After Market	$-44,800	-5.58%
05/10/2021	After Market	$-44,800	-24.78%
03/15/2021	After Market	$-64,000	-30.72%
11/09/2020	Before Market	$-57,600	19.79%
08/10/2020	Before Market	$-147,200	-0.22%
05/12/2020	Before Market	$-192,000	6.63%
03/24/2020	After Market	$-1,830,400	-88.18%
11/08/2019	After Market	$-3,641,600	-28.24%
08/12/2019	Before Market	$-6,080,000	5.60%
05/13/2019	Before Market	$-8,256,000	-17.10%
03/18/2019	Before Market	$-39,040,000	-63.25%
11/09/2018	Before Market	$-36,480,000	7.25%
08/13/2018	Before Market	$-46,720,000	9.98%
05/11/2018	After Market	$-56,320,000	-23.25%
03/09/2018	After Market	$-43,520,000	13.98%
11/06/2017	After Market	$-49,280,000	-7.84%
08/11/2017	After Market	$-41,600,000	18.30%
05/12/2017	After Market	$-81,280,000	8.45%
04/13/2017	After Market	$-190,080,000	-123.98%
11/10/2016	After Market	$-185,600,000	15.55%
08/05/2016	After Market	$-320,000,000	10.33%
05/09/2016	Before Market	$-473,600,000	-15.77%
03/04/2016	Before Market	$-454,400,000	-5.47%
11/09/2015	Before Market	$-460,800,000	-13.85%
08/07/2015	After Market	$-467,200,000	-10.11%
05/08/2015	After Market	$-454,400,000	-30.11%
03/03/2015	Before Market	$-531,200,000	-0.46%
11/07/2014	After Market	$-454,400,000	-0.88%
08/08/2014	After Market	$-390,400,000	-12.84%
05/13/2014	---	$-377,600,000	-65.27%
03/31/2014	Before Market	$-473,600,000	-57.72%
11/13/2013	After Market	$-556,800,000	-33.27%

More About Tonix Pharmaceuticals Holding Corp

Website

https://www.tonixpharma.com

Country

USA

Full Time Employees

142

Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia. It also markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. In addition, the company develops TNX-102 SL, a cyclobenzaprine HCl sublingual tablet for the treatment of major depressive disorder and acute stress reaction/acute stress disorder; TNX-1300, a double-mutant cocaine esterase for the treatment of cocaine intoxication; TNX-1500, an Fc-modified humanized monoclonal antibody to prevent kidney transplant rejection, as well as to treat autoimmune conditions; TNX-4800, a humanized monoclonal antibody for the seasonal prevention of Lyme disease; and TNX-2900, an intranasal oxytocin potentiated with magnesium for the treatment of Prader-Willi syndrome. Further, it is developing TNX-1900, an intranasal potentiated oxytocin for the treatment of binge eating disorder, adolescent obesity, and bone health in pediatric autism, and arginine-vasopressin deficiency; TNX-801, a live horsepox vaccine for the prevention of smallpox and mpox; TNX-4200, a small molecule broad-spectrum antiviral agent targeting CD45 for the treatment or prevention of viral disease; TNX-4900, a highly selective small-molecule Sigma-1 receptor antagonist for neuropathic pain; TNX-1700, a recombinant Trefoil Factor Family 2 fusion protein for the treatment of gastric and colorectal cancers; and TNX-1800 and TNX-1850, live modified horsepox vaccines for the prevention of COVID. Tonix Pharmaceuticals Holding Corp. was founded in 2007 and is based in Berkeley Heights, New Jersey.

“Tonix Pharmaceuticals Holding Corp Earnings” Can Refer to the Tonix Pharmaceuticals Holding Corp Earnings Date

Some people say “Tonix Pharmaceuticals Holding Corp earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Tonix Pharmaceuticals Holding Corp position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Tonix Pharmaceuticals Holding Corp Stock on the Earnings Date

If you own Tonix Pharmaceuticals Holding Corp stock (TNXP) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Tonix Pharmaceuticals Holding Corp might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Tonix Pharmaceuticals Holding Corp shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Tonix Pharmaceuticals Holding Corp Earnings

You can contact us any time if you would like to ask questions about Tonix Pharmaceuticals Holding Corp earnings or anything else related to the stock market.